Corneal Implant Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026


Posted August 12, 2019 by FutureWise20

Corneal implant market is projected to value over US$ 500 million by the end of 2026 and record a CAGR of over 6% during the forecast period of 2019-2026.

 
Corneal implant market is projected to value over US$ 500 million by the end of 2026 and record a CAGR of over 6% during the forecast period of 2019-2026.
The rise of visual media has resulted in the straining of our eyes. Problems like eye irritation caused by lack of sleep due to binge-watching TV shows and movies are very prominent. And to top it all, not everyone seems to be wearing sunglasses when they go out on in the sun which exposes their eyes to harmful UV rays. This UV ray overexposure results in causing keratoconus. In this disease, there occurs thinning of the cornea which is round in shape normally and in turn bulges into a conical shape. This shape of cornea causes deflection of light when it enters the eye on its way to the retina which is light-sensitive and therefore it leads to distorted vision. Keratoconus generally occurs during the adolescent time or in the early 20’s and it can happen to either one or both the eyes. To treat keratoconus, various treatments are available like corneal crosslinking which prevents the corneal tissue from bulging further and strengthens it. Different types of lenses, like a custom soft contact lens, gas permeable contact lens, hybrid contact lens, scleral and semi-scleral lenses, prosthetic lenses are also used to treat keratoconus. Intacs and topography-guided conductive keratoplasty are also some of the treatments. But in some cases, the keratoconus reaches a point where a person becomes unable to tolerate a sturdy contact lens and also therapies are no longer helpful in providing a good vision. In that case, corneal implant is the last resort. There are different types of corneal implants available like refractive corneal implants, corneal reshaping and small aperture implants.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=189&page=requestsample
Insights on Corneal Implants, By Region:
North America is expected to be a dominant market due to the high rise of awareness among common people followed by Europe region as it also possesses a huge amount of share in the global market. Asia- Pacific and Europe are expected to witness significant growth in the global market during the forecast period. Local manufacturers are currently dominating the Asia-Pacific region and this trend will continue during the entire forecast period. Latin America and Rest of the World account for a very small fraction of market share.
Corneal Implant Market Segmentation:
1. By Implant type
• Refractive Corneal Implant
• Corneal Reshaping implant
• Small Aperture Corneal implants
2. By End User
• Hospital
• Clinic
3. By region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest of the World

Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=189&page=askfordiscount
Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global corneal implant market by implant type, by end user, by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies.

Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Corneal Implant Market Overview
1.4.1.1. Global Corneal Implant Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Corneal Implant
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Corneal Implant Market Revenue (USD Mn), 2018-2026 by Implant Type
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Implant Type, 2018-2026
1.7.1.4.1.1. Refractive Corneal Implant
1.7.1.4.1.2. Corneal Reshaping implant
1.7.1.4.1.3. Small Aperture Corneal implants
1.8. Global Corneal Implant Market Revenue (USD Mn), 2018-2026 by End User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.8.1.4.1.1. Hospital
1.8.1.4.1.2. Clinic
1.9. Global Corneal Implant Market Revenue (USD Mn), 2018-2026 by Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026
1.9.1.4.1.1. North America
1.9.1.4.1.2. Latin America
1.9.1.4.1.3. Europe
1.9.1.4.1.4. Asia Pacific
1.9.1.4.1.5. Rest of world
1.10. North America Corneal Implant Market Revenue (US$ Mn), 2018-2026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.10.1.4.1.1. US
1.10.1.4.1.2. Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Implant Type, 2018-2026
1.10.1.5.1.1. Refractive Corneal Implant
1.10.1.5.1.2. Corneal Reshaping implant
1.10.1.5.1.3. Small Aperture Corneal implants
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.10.1.6.1.1. Hospital
1.10.1.6.1.2. Clinic
1.11. Latin America Corneal Implant Market Revenue (US$ Mn), 2018-2026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.11.1.4.1.1. Brazil
1.11.1.4.1.2. Mexico
1.11.1.4.1.3. Argentina
1.11.1.4.1.4. Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Implant Type, 2018-2026
1.11.1.5.1.1. Refractive Corneal Implant
1.11.1.5.1.2. Corneal Reshaping implant
1.11.1.5.1.3. Small Aperture Corneal implants
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.11.1.6.1.1. Hospital
1.11.1.6.1.2. Clinic
1.12. Europe America Corneal Implant Market Revenue (US$ Mn), 2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.12.1.4.1.1. Germany
1.12.1.4.1.2. France
1.12.1.4.1.3. Spain
1.12.1.4.1.4. UK
1.12.1.4.1.5. Russia
1.12.1.4.1.6. Poland
1.12.1.4.1.7. Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Implant Type, 2018-2026
1.12.1.5.1.1. Refractive Corneal Implant
1.12.1.5.1.2. Corneal Reshaping implant
1.12.1.5.1.2.1. Small Aperture Corneal implants
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.12.1.6.1.1.1. Hospital
1.12.1.6.1.1.2. Clinic
1.13. Asia Pacific America Corneal Implant Market Revenue (US$ Mn), 2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.13.1.4.1.1. Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2. Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Implant Type, 2018-2026
1.13.1.5.1.1. Subscription based Services
1.13.1.5.1.2. Ownership
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.13.1.6.1.1. Biopharmaceutical Companies
1.13.1.6.1.2. Contract Research Organization
1.13.1.6.1.3. Academic Institutes
1.14. Rest of World America Corneal Implant Market Revenue (US$ Mn), 2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026
1.14.1.4.1.1. Middle East
1.14.1.4.1.2. South Africa
1.14.1.4.1.3. North Africa
1.14.1.4.1.4. Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Implant Type, 2018-2026
1.14.1.5.1.1. Refractive Corneal Implant
1.14.1.5.1.2. Corneal Reshaping implant
1.14.1.5.1.3. Small Aperture Corneal implants
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End User, 2018-2026
1.14.1.6.1.1. Hospital
1.14.1.6.1.2. Clinic
1.15. Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1. AJL Ophthalmic, S.A.
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2. SMR Ophthalmic Pvt. Ltd.
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3. Aurolab
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4. LinCor Biosciences Pte Ltd.
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5. Ophtec BV
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6. DIOPTEX Medizinprodukte Forschungs-, Entwicklungs- und Vertriebs GmbH
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
1.15.1.3.1.7. Surgical Specialties Corp
1.15.1.3.1.7.1.1. Corporate Overview
1.15.1.3.1.7.1.2. Financial Performance
1.15.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.7.1.4. Company Strategy & Channel Management
1.16. Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry - a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By FutureWise Market Research & Reports
Country India
Categories Biotech
Last Updated August 12, 2019